Most peptide degradation in practice is caused by handling rather than by synthesis quality, and a few storage decisions prevent most of it.
Key Takeaways
- Lyophilised peptide is far more stable than peptide in solution, and frozen solution is more stable than refrigerated solution.
- Tryptophan, tyrosine, methionine, and cysteine are all susceptible to photo- or oxidative damage.
- Record storage temperature, number of freeze-thaw cycles, and the date each aliquot was prepared.
Temperature and form
Lyophilised peptide is far more stable than peptide in solution, and frozen solution is more stable than refrigerated solution. Dry material at low temperature is the default long-term condition unless stability data support otherwise.
The freeze-thaw problem
Repeated freeze-thaw cycles drive aggregation through concentration effects at the ice interface and through pH shifts during freezing. Aliquoting into single-use volumes before freezing is the single most effective control.
For related mechanism work, see oral peptide bioavailability.
Light and oxidation
Tryptophan, tyrosine, methionine, and cysteine are all susceptible to photo- or oxidative damage. Amber vials, minimal headspace, and inert-gas overlay are cheap protections where those residues are present.
Adsorption to surfaces
Peptides adsorb to glass and to many plastics, which matters most at low concentration where losses are proportionally large. Low-binding consumables and carrier protein or surfactant addition reduce the problem.
Documentation
Record storage temperature, number of freeze-thaw cycles, and the date each aliquot was prepared. Most unexplained potency drift resolves to a handling variable that nobody wrote down.
Experimental Conditions and Practical Setup
Stability is assessed by holding aliquots under the intended storage condition and at accelerated conditions, sampling at defined intervals, and analysing by both a purity method and a size-exclusion method. Excursions are logged with duration, because an unrecorded temperature excursion makes any later potency change impossible to explain.
Storage form ranking by typical stability
| Form | Relative stability | Main risk |
|---|---|---|
| Lyophilised, frozen, desiccated | Highest | Moisture uptake on opening |
| Lyophilised, refrigerated | High | Slow degradation if moisture present |
| Frozen solution, single-use aliquots | Moderate | Freeze-thaw if aliquot reused |
| Refrigerated solution | Lowest | Aggregation and chemical degradation |
Practical Notes for the Bench
- Aliquot before freezing to eliminate repeat freeze-thaw cycles.
- Use low-binding plastics when working at low concentration.
- Log temperature and cycle count for every aliquot.
Frequently Asked Questions
How long does peptide in solution last?
Far less long than lyophilised material; refrigerated solutions are usually viable for days to weeks depending on sequence, and should be aliquoted and frozen for longer storage.
Why do I lose material at low concentration?
Surface adsorption to glass and plastic consumes a proportionally large fraction when concentrations are low.
Is amber glass necessary?
It is a cheap safeguard whenever aromatic or sulfur-containing residues are present.
How many freeze-thaw cycles are acceptable?
None, if avoidable. Each cycle concentrates the peptide at the ice interface and shifts pH during freezing, so single-use aliquots are the standard control.
Related Reading
- oral peptide bioavailability
- peptide PEGylation
- peptide excipient compatibility
- solid-phase peptide synthesis
- peptide waste disposal
References & Further Reading
- Kordulewska NK et al. Stability of interleukin-1β, -4, -6, -8, -10, -13, interferon-γ and tumor necrosis factor-α in human sera after repetitive freeze-thaw cycles and long storage. J Pharm Biomed Anal. 2021. PubMed 33535109
- Simpson S et al. Thermal stability of cytokines: A review. Cytokine. 2020. PubMed 31472404
- Peptide literature search on PubMed
- Full-text archive at PubMed Central
- FDA guidance documents on peptide drug products
Educational content for research staff. Nothing here should be read as advice on human or veterinary use of any compound.
Reviewed by James Okoro, BSc, Laboratory Operations & Documentation.